These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 1105663)

  • 41. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunotherapy for malignant disease.
    Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
    [No Abstract]   [Full Text] [Related]  

  • 43. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
    Gandhi NM; Morales A; Lamm DL
    BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG; Sparks FC; Morton DL
    Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL; Reif AE; Shklar G
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract]   [Full Text] [Related]  

  • 46. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 47. BCG and cancer.
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
    [No Abstract]   [Full Text] [Related]  

  • 48. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
    J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
    [No Abstract]   [Full Text] [Related]  

  • 49. BCG in the therapy of cancer.
    Delmonte L; Oettgen HF
    Clin Bull; 1975; 5(2):69-71. PubMed ID: 776445
    [No Abstract]   [Full Text] [Related]  

  • 50. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of antitumor immunity--immunobiologic approaches.
    North RJ; Dye ES; Mills CD; Chandler JP
    Springer Semin Immunopathol; 1982; 5(2):193-220. PubMed ID: 6293113
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 57. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunotherapy in the management of myelogenous leukemia.
    Fairley GH
    Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.
    Lipton A; Harvey HA; Balch CM; Antle CE; Heckard R; Bartolucci AA
    J Clin Oncol; 1991 Jul; 9(7):1151-6. PubMed ID: 2045856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy of cancer.
    Holmes EC; Morton DL; Eilber FR
    West J Med; 1977 Feb; 126(2):102-9. PubMed ID: 322390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.